Saturday, August 10, 2024

Merck to buy experimental drug targeting B-cell diseases for up to $1.3 billion

Merck to buy experimental drug targeting B-cell diseases for up to $1.3 billionMerck to buy experimental drug targeting B-cell diseases for up to $1.3 billion

at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Semiconductor Recycling: Addressing E-Waste Challenges

Semiconductor Recycling: Addressing E-Waste Challenges The increasing demand for electronic devices, from smartphones to electric cars, has ...